PUBMED FOR HANDHELDS

Journal Abstract Search


298 related items for PubMed ID: 3004094

  • 21. Cushing's syndrome due to adrenal adenoma with persistent diurnal cortisol secretory rhythm.
    Olsen NJ, Fang VS, DeGroot LJ.
    Metabolism; 1978 Jun; 27(6):695-700. PubMed ID: 206799
    [Abstract] [Full Text] [Related]

  • 22. Characterization of adrenal autonomy in Cushing's syndrome: a comparison between in vivo and in vitro responsiveness of the adrenal gland.
    Lamberts SW, Zuiderwijk J, Uitterlinden P, Blijd JJ, Bruining HA, de Jong FH.
    J Clin Endocrinol Metab; 1990 Jan; 70(1):192-9. PubMed ID: 2152930
    [Abstract] [Full Text] [Related]

  • 23. Bilateral adrenocortical adenomas causing ACTH-independent Cushing's syndrome at different periods: a case report and discussion of corticosteroid replacement therapy following bilateral adrenalectomy.
    Tung SC, Wang PW, Huang TL, Lee WC, Chen WJ.
    J Endocrinol Invest; 2004 Apr; 27(4):375-9. PubMed ID: 15233560
    [Abstract] [Full Text] [Related]

  • 24. Cushing's syndrome presenting the coexistence of a pituitary corticotrophic cell hyperplasia and a unilateral functional adrenal adenoma.
    Watanobe H, Kawagishi T, Hirai Y, Sato T, Tsutsui M, Kamata Y, Takebe K.
    Acta Endocrinol (Copenh); 1985 Nov; 110(3):302-7. PubMed ID: 3000119
    [Abstract] [Full Text] [Related]

  • 25. Lysine vasopressin stimulation of cortisol secretion in patients with adrenocorticotropin-independent macronodular adrenal hyperplasia.
    Horiba N, Suda T, Aiba M, Naruse M, Nomura K, Imamura M, Demura H.
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2336-41. PubMed ID: 7629226
    [Abstract] [Full Text] [Related]

  • 26. Reduced serum levels of dehydroepiandrosterone sulphate in adrenal incidentalomas: a marker of adrenocortical tumour.
    Flecchia D, Mazza E, Carlini M, Blatto A, Olivieri F, Serra G, Camanni F, Messina M.
    Clin Endocrinol (Oxf); 1995 Feb; 42(2):129-34. PubMed ID: 7704956
    [Abstract] [Full Text] [Related]

  • 27. Effectiveness versus efficacy: the limited value in clinical practice of high dose dexamethasone suppression testing in the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome.
    Aron DC, Raff H, Findling JW.
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1780-5. PubMed ID: 9177382
    [Abstract] [Full Text] [Related]

  • 28. Possible pre-Cushing's syndrome due to an adrenal adenoma incidentally discovered.
    Tsuboi Y, Ishikawa S, Fujisawa G, Okada K, Saito T.
    Endocr J; 1995 Aug; 42(4):509-16. PubMed ID: 8556058
    [Abstract] [Full Text] [Related]

  • 29. Incidentally discovered adrenal mass (incidentaloma): investigation and management of 208 patients.
    Kasperlik-Zeluska AA, Rosłonowska E, Słowinska-Srzednicka J, Migdalska B, Jeske W, Makowska A, Snochowska H.
    Clin Endocrinol (Oxf); 1997 Jan; 46(1):29-37. PubMed ID: 9059555
    [Abstract] [Full Text] [Related]

  • 30. A reappraisal of the ovine corticotropin-releasing hormone stimulation test in the differential diagnosis of Cushing's syndrome: a comparison with the standard high-dose dexamethasone suppression test.
    Lee TI, Lin SY, Won JG, Tang KT, Jap TS, Kwok CF, Lin HD.
    Zhonghua Yi Xue Za Zhi (Taipei); 2002 Oct; 65(10):474-82. PubMed ID: 12523812
    [Abstract] [Full Text] [Related]

  • 31. Preclinical Cushing's syndrome in patients with an adrenal incidentaloma.
    Tjan-Heijnen VC, Hermus AR, Kemink SA, Mudde AH, Pieters GF, Smals AG, Kloppenborg PW.
    Neth J Med; 1998 Mar; 52(3):111-5. PubMed ID: 9599968
    [Abstract] [Full Text] [Related]

  • 32. The 24-h cortisol secretory pattern in Cushing's syndrome.
    Tourniaire J, Chalendar D, Rebattu B, Fevre-Montange M, Bajard L, Mazenod B, Dechaud H, Abou Samra AB, van Cauter E.
    Acta Endocrinol (Copenh); 1986 Jun; 112(2):230-7. PubMed ID: 3017037
    [Abstract] [Full Text] [Related]

  • 33. [A case of Cushing's disease associated with a non-functioning adrenal tumor].
    Ohguni S, Takagi C, Masaki Y, Notsu K, Hori T, Kato Y.
    Nihon Naibunpi Gakkai Zasshi; 1992 Dec 20; 68(12):1249-56. PubMed ID: 1291336
    [Abstract] [Full Text] [Related]

  • 34. Comparison between the suppressive effects of dexamethasone and loperamide on cortisol and ACTH secretion in some pathological conditions.
    Bernini GP, Argenio GF, Cerri F, Franchi F.
    J Endocrinol Invest; 1994 Nov 20; 17(10):799-804. PubMed ID: 7699214
    [Abstract] [Full Text] [Related]

  • 35. An unusual profile of endocrine study in a patient with pre-Cushing's syndrome.
    Kodama C, Nakada T, Sasagawa I, Ishigooka M, Yamaguchi T, Suzuki H.
    Int Urol Nephrol; 1993 Nov 20; 25(6):517-24. PubMed ID: 8175270
    [Abstract] [Full Text] [Related]

  • 36. Single intravenous bolus of dexamethasone for the differential diagnosis of Cushing's syndrome.
    Shilo S, Rösler A.
    J Pediatr Endocrinol Metab; 1995 Nov 20; 8(1):27-33. PubMed ID: 7584693
    [Abstract] [Full Text] [Related]

  • 37. [A case of pre-Cushing's syndrome].
    Ichikawa T, Shiseki Y, Sumiya H, Isaka S, Shimazaki J, Terano T, Kobayashi H, Yamamoto K, Tamura Y, Yoshida S.
    Hinyokika Kiyo; 1992 Sep 20; 38(9):1031-5. PubMed ID: 1329452
    [Abstract] [Full Text] [Related]

  • 38. [Cushing's syndrome: diagnostic exploration].
    Tabarin A, Roger P.
    Presse Med; 1992 Sep 20; 23(1):43-8. PubMed ID: 8127815
    [Abstract] [Full Text] [Related]

  • 39. [Diagnosis and differential diagnosis of Cushing's syndrome].
    Penezić Z, Zarković M, Vujović S, Drezgić M.
    Srp Arh Celok Lek; 2006 Sep 20; 134(11-12):558-66. PubMed ID: 17304774
    [Abstract] [Full Text] [Related]

  • 40. Adrenocorticotropin- and cortisol-releasing effect of hexarelin, a synthetic growth hormone-releasing peptide, in normal subjects and patients with Cushing's syndrome.
    Ghigo E, Arvat E, Ramunni J, Colao A, Gianotti L, Deghenghi R, Lombardi G, Camanni F.
    J Clin Endocrinol Metab; 1997 Aug 20; 82(8):2439-44. PubMed ID: 9253314
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 15.